30.04.2013 Views

2007, Piran, Slovenia

2007, Piran, Slovenia

2007, Piran, Slovenia

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Environmental Ergonomics XII<br />

Igor B. Mekjavic, Stelios N. Kounalakis & Nigel A.S. Taylor (Eds.), © BIOMED, Ljubljana <strong>2007</strong><br />

EFFECT OF ANTI-MOTION SICKNESS DRUGS ON MOTION<br />

SICKNESS-INDUCED PREDISPOSITION TO HYPOTHERMIA<br />

Gerard Nobel 1 , Ola Eiken 2 , Arne Tribukait 2 , Roger Kölegård 2 , Igor B. Mekjavic 3<br />

1 Royal Netherlands Navy, Nethertlands<br />

2 Swedish Defense Research Agency, Karolinska Institute, Berzelius v. 13, SE-17177<br />

Stockholm, Sweden<br />

3 Department of Automation, Biocybernetics and Robotics, Jozef Stefan Institute, Jamova 39,<br />

SI-1000, Ljubljana, Slovania<br />

Contact person: nobel_gerard@hotmail.com<br />

INTRODUCTION<br />

Previous studies have shown that motion sickness (MS) potentiates the cooling rate of the<br />

body core during immersion, both in luke-warm water (28°C) 1 and cold water (15°C) 2 . The<br />

aim of the present study was to investigate whether it is possible to influence this MSinduced<br />

predisposition to hypothermia by administering two commonly used anti-MS drugs,<br />

namely the histamine-receptor blocker dimenhydrinate (Amosyt®) and the muscarinereceptor<br />

blocker scopolamine (Scopoderm®).<br />

METHODS<br />

The study was approved by the Human Ethics Committee at the Karolinska Institute. After<br />

giving their informed consent 9 healthy male subjects participated in 5 experimental<br />

conditions. The subjects’ mean (range) age, weight, and length were 25 (23-27) year, 73 (60-<br />

83) kg and 1.80 (1.68-1.87) m, respectively. After baseline recording and administration of<br />

certain combinations of the two drugs and their respective placebo substances each subject<br />

was immersed in 15°C water for a maximum of 90 minutes or till the core temperature had<br />

dropped 2°C or had reached 35°C. The experimental conditions were:<br />

1. Control: no MS provocation, no medication.<br />

2. Control MS: MS provocation, no medication.<br />

3. Placebo MS: placebo Amosyt® and placebo Scopoderm®, MS provocation .<br />

4. Amo MS: Amosyt® medication, MS provocation.<br />

5. Scop MS: Scopoderm® medication, MS provocation.<br />

MS provocation was induced by the use of a rotating chair in combination with a regimen of<br />

standardized head movements. Throughout the experiments rectal temperature, mean skin<br />

temperature, the difference in temperature between forearm and 3 rd finger of the right hand,<br />

oxygen uptake, heart rate and blood pressure were recorded, but only the results of the rectal<br />

temperature are presented here. At 5-min intervals (after MS provocation) each subject rated<br />

motion sickness, thermal comfort and temperature perception.<br />

RESULTS AND DISCUSSION<br />

Amosyt® and Scopoderm® were similarly efficacious in ameliorating nausea during and<br />

after the MS provocation. During immersion the core cooling rate (∆ rectal temperature) was<br />

28 % greater in the MS control condition than in the Control condition (p

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!